Get started Log in

ORTX — Orchard Therapeutics Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Market Cap
$378.06m
Enterprise Value
$278.24m
Revenue
$22.66m

Brief: Orchard Therapeutics, Fondazione Telethon And Ospedale San Raffaele Announce Exclusive Worldwide License Agreement For Treatment Of MPS-I
28/05/2019 12:47
Brief: Orchard Therapeutics PLC Posts Qtrly Loss Per Share $0.35
28/05/2019 12:27
Brief: Orchard Therapeutics Announces Clinical Proof-Of-Concept Data For Gene Therapy OTL-300
29/04/2019 12:18
Brief: Orchard Therapeutics Announces First Patient Dosed With Cryopreserved Formulation Of Otl-103 Gene Therapy For The Treatment Of Wiskott-Aldrich Syndrome
25/04/2019 14:06
Brief: Orchard Therapeutics Announces Presentation Of Clinical Proof-Of-Concept For Otl-300
15/04/2019 16:14
Brief: Orchard Therapeutics Reports 2018 Financial Results And Reviews Recent Business Highlights
21/03/2019 11:23
Brief: Orchard Therapeutics Presents Two-Year Follow-Up Data Versus Historical Control From Registrational Trial Of Otl-101
22/02/2019 14:01
Brief: Temasek Holdings (Private) Ltd Reports Share Stake In Tencent Music Entertainment; Takes Share Stake in Guardant Health and Orchard Therapeutics
14/02/2019 12:15
Brief: Orchard Therapeutics PLC Says Entering 2019 With $340M In Cash And Investments
07/01/2019 13:12
Brief: Orchard Therapeutics And Sirion Biotech Announce Licensing Agreement
14/12/2018 12:35
Brief: Orchard Therapeutics Announces The Build-Out Of New Gene Therapy Manufacturing Facility In California
13/12/2018 12:36
NASDAQ RESUMED
31/10/2018 14:43
NASDAQ TRADE HALT REASON NOT AVAILABLE
31/10/2018 08:00
Brief: Orchard Therapeutics Says Pricing Of Initial Public Offering
31/10/2018 03:17